본문 바로가기
KERD
논문KCI 등재

한의학 관련 무작위배정비교임상연구의 비뚤림 위험 평가

The Assessment of Risk of Bias on Randomised Controlled Trials of Oriental Medicine in Korea

1

조회

0

다운로드

7

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: To examine the current status of clinical research in oriental medicine, and to assess ‘risk of bias’(ROB) of randomized clinical trials(RCTs) in oriental medicine in Korea. Methods: Special committee for EBM, KOMS(Korean Oriental Medicine Society) reviewed 17 journals related to oriental medicine in Korea (from the first issue to May 2010), the Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 2, 2010), and PubMed (1966 to May 2010). Then we selected eligible RCTs in terms of oriental medicine, and assessed ‘risk of bias’. Results: We reviewed 12,653 articles from the 17 journals, and 41 articles from CENTRAL and PubMed. After non-clinical articles were excluded, 1,004 articles were left. Among them, the number of eligible studies in terms of oriental medicine was 306. In these eligible studies, 130 were RCTs. Of RCTs, 69 were on acupuncture, 25 on herbal medicine. The proportion of ‘unclear’ is high in the criteria of ‘Allocation concealment’, ‘Blinding of participants and personnel’, ‘Blinding of outcome assessment’ and ‘Other bias’. On the other hand, ‘low’ has high in the criteria of ‘Incomplete outcome data’ and ‘Selective reporting’. Conclusions: Risk of bias on oriental medicine is unclear in terms of ‘allocation concealment’ and ‘blinding’. For high-quality research in oriental medicine, further research should be needed on randomization and blinding in the RCTs.

Abstract

Objectives: To examine the current status of clinical research in oriental medicine, and to assess ‘risk of bias’(ROB) of randomized clinical trials(RCTs) in oriental medicine in Korea. Methods: Special committee for EBM, KOMS(Korean Oriental Medicine Society) reviewed 17 journals related to oriental medicine in Korea (from the first issue to May 2010), the Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 2, 2010), and PubMed (1966 to May 2010). Then we selected eligible RCTs in terms of oriental medicine, and assessed ‘risk of bias’. Results: We reviewed 12,653 articles from the 17 journals, and 41 articles from CENTRAL and PubMed. After non-clinical articles were excluded, 1,004 articles were left. Among them, the number of eligible studies in terms of oriental medicine was 306. In these eligible studies, 130 were RCTs. Of RCTs, 69 were on acupuncture, 25 on herbal medicine. The proportion of ‘unclear’ is high in the criteria of ‘Allocation concealment’, ‘Blinding of participants and personnel’, ‘Blinding of outcome assessment’ and ‘Other bias’. On the other hand, ‘low’ has high in the criteria of ‘Incomplete outcome data’ and ‘Selective reporting’. Conclusions: Risk of bias on oriental medicine is unclear in terms of ‘allocation concealment’ and ‘blinding’. For high-quality research in oriental medicine, further research should be needed on randomization and blinding in the RCTs.

참고문헌 (12)

  1. Sackett DL, "Evidence based medicine: what it is and what it isn't", Bmj, 312(7023), pp.71~72 (1996)
  2. 정우빈, "대한가정의학회지에 실린 무작위대조시험논문의 질 평가", Korean Journal of Family Medicine, 30(8), pp.626~631 (2009), 대한가정의학회
  3. 김석원, "국내 학회지에 실린 무작위임상시험논문의 양적 분석 및 질 평가 - 5개 학회지를 대상으로", Korean Journal of Family Medicine, 25(2), pp.118~125 (2004), 대한가정의학회
  4. 최준용, "대한한의학회지 및 대한한의학회 산하 정회원 학회의 학술진흥재단 등재지에 대한 천식 임상연구의 체계적 고찰", 대한한의학회지, 31(1), pp.14~22 (2010), 대한한의학회
  5. 이규선, "대한한의학회지 및 대한한의학회 산하 정회원 학회의 학술진흥재단 등재지에 대한 비염 임상연구의 체계적 고찰", 대한한의학회지, 31(5), pp.1~11 (2010), 대한한의학회
  6. 박봉기, "무작위 배정 비교 임상 시험을 통한 국내의 약침 연구에 대한 체계적 고찰", 대한한의학회지, 30(5), pp.115~126 (2009), 대한한의학회
  7. Systems to Rate the Strength of Scientific Evidence. Evidence Report, "Technology Assessment No. 47 (Prepared by the Research Triangle Institute--University of North Carolina Evidence-based Practice Center under Contract No. 290-97-0011)", West S, 2002, 02-E016
  8. NECA 체계적 문헌고찰 매뉴얼, "김수영", 한국보건의료연구원, 82~85 (2011)
  9. Moher D, "CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials", British Medical Journal, 340, pp.c869~ (2010)
  10. MacPherson H, "Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations", The Journal of Alternative & Complementary Medicine, 8(1), pp.85~89 (2002)
  11. Pildal J, "Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials", International Journal of Epidemiology, 36, pp.847~857 (2007)

관련 논문AI추천

국내 한약 처방을 이용한 무작위 배정 임상연구논문의 질 평가김윤영, 유종향, 이수경, 이시우한의병리학회 · 동의생리병리학회지2011 · 제25권 제5호국내 한의학 관련 학술지에 게재된 전향적 임상연구의 윤리적 측면 분석권지혜, 김윤영, 유종향, 이시우한의병리학회 · 동의생리병리학회지2012 · 제26권 제6호한의 임상 연구에 대한 국내외 현황 및 논쟁에 관한 고찰 - 미래 임상 연구 전략 Ⅰ-고성규, 고호연, 김태훈, 박정수, 박종형, 선승호, 송윤경, 이충열, 임은미, 전찬용, 정기용, 정종진, 최유경, 홍성인한의병리학회 · 동의생리병리학회지2014 · 제28권 제2호한약제제 무작위 대조군 연구에서 대조군 설계의 문제점과 대안윤영희, 최인화대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2008 · 제21권 제2호한약 임상시험의 특성 : 질병관리본부 임상연구정보서비스(CRIS)를 중심으로전선우, 정창운, 조희근대한한방내과학회 · 대한한방내과학회지2020 · 제41권 제6호CONSORT-CHM 2017 지침에 근거한 대한한의학회지 및 회원학회지에 투고된 경구투여 한약 중재를 활용한 무작위 배정 비교 임상 연구(RCT)의 양적, 질적 평가 연구문세훈, 우현준, 이정한, 전병현, 조정호, 최승관, 하원배, 한윤희대한한방내과학회 · 대한한방내과학회지2023 · 제44권 제6호

이 간행물의 다른 논문 (17건)